Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum]

Toshida H, Funaki T, Ono K, et al. Drug Des Devel Ther. 2017;11:1871- 1879 The authors have advised there are some mistakes in themean changes and standard errors of the paper: 1. The standard errors of groups Placebo and VApal wereall the same value for staining and symptom scores inFigure 1 (on page 1875) and Figure 3 (on page 1876),and Table 3 (on page 1877). 2. There were slight discrepancies in the Mean changes ofPlacebo group at 1, 2 and 4 weeks in Figure 3D. 3. There was a slight discrepancy in the Mean change offoreign body sensation in Placebo group at 1 week inTable 3. The authors have advised the errors were due to: 1. The standard error listed in a different table on thestatistical analysis software was adopted. 2. There were typing errors when transferring numericalvalues from statistical analysis software to graph creationsoftware. 3. There was a mistake when rounding numerical value. Since the statistical analysis had been performed using theoriginal mean values (correct values), all results do notchange. The authors apologize for these errors and advise they donot affect the results of the paper. Read the original article